Mount Sinai Recognized for Spine and Neuroscience Programs

Mount Sinai Health System secured a distinguished position on Becker’s Hospital Review’s “Hospitals and Health Systems With Spine and Neuroscience Programs to Know” list for 2023, which recognizes programs in the United States renowned for excellent outcomes, leading surgical techniques, and cutting-edge research.

“This recognition underscores our dedication to advancing neurosurgical and neurological patient outcomes now and for the future,” says Joshua B. Bederson, MD, Leonard I. Malis, MD / Corinne and Joseph Graber Professor of Neurosurgery and Chair of Neurosurgery at Mount Sinai Health System. “With the continued recruitment of outstanding neurosurgical talent, and the expansion of specialized clinical programs and technology in New York City and Long Island, we have enhanced accuracy and safety, and improved outcomes.”

Joshua B. Bederson, MD

The Department of Neurosurgery has 50 specialists and 120 advanced practice providers providing expert clinical care, offering treatments for a variety of neurological conditions such as brain tumors, vascular malformations, spinal disorders, epilepsy, neurotrauma, pain management, and neuromodulation.

The report in Becker’s noted the Department has 191 active neurosurgery-led trials that offer clinical trial management and cost-effective patient solutions. The Department is ranks No. 1 in New York State and No. 15 in the nation for research funded by the National Institutes for Health, according to the Blue Ridge Institute for Medical Research. It has maintained a 19 percent market share in New York City’s neurosurgery inpatient market since 2016.

Mount Sinai was recognized by Becker’s for outstanding achievements including:

  • A commitment to advancing innovation and technology through state-of-the-art facilities housing advanced technologies that improve patient outcomes; collaboration with AI-powered diagnostic tool Viz.ai to harness technology solutions in care; and leading the world in adopting “machine-vision” systems for open spine and brain surgery.
  • An outstanding residency program and three fellowship programs with a track record of producing top clinical leaders.

This was the latest recognition for the Department of Neurosurgery. The Mount Sinai Hospital was ranked No. 8 in Neurosurgery in Newsweek’s “World’s Best Specialized Hospitals 2023.” The Mount Sinai Hospital was ranked No. 9 in Neurology and Neurosurgery in the nation in 2023-2024 by U.S. News & World Report®.

To schedule a patient for neurosurgery or spine surgery, call 212-241-2377.

Mount Sinai Hosts Landmark Symposium on Urologic Oncology

James Tisch, left, Co-Chairman of the Boards of Trustees of the Mount Sinai Health System, and Ash Tewari, MBBS, MCh, Chair of the Milton and Carroll Petrie Department of Urology.

The Department of Urology at the Icahn School of Medicine at Mount Sinai recently took center stage in the global medical community by hosting the Fifth International Prostate Cancer Symposium and World Congress of Urologic Oncology.

The event, held Friday, December 8, to Sunday, December 10, is considered a cornerstone in prostate, kidney, and bladder cancer. The event drew more than 500 registrants, including 90 of the world’s most renowned experts from more than 20 countries, and showcased groundbreaking research and clinical practices poised to redefine cancer care and impact patient outcomes worldwide.

A significant highlight was the presentation of the first Golden Robot Surgical Award for Excellence in Surgical Innovations for Cancer Patients to Ash Tewari, MBBS, MCh, Chair of the Milton and Carroll Petrie Department of Urology at Icahn Mount Sinai. This award was presented by Merryl and James Tisch, Co-Chairman of the Boards of Trustees of the Mount Sinai Health System, during a gala at the Pierre Hotel. The award recognizes a significant leap in medical innovation and patient care. Also attending were Brendan Carr, MD, MA, MS, whose appointment as Chief Executive of the Mount Sinai Health System is effective early next year, who opened the gala event, and Margaret Pastuszko, President and Chief Operating Officer.  Click here to watch a video shown at the gala titled “A Decade of Excellence: Dr. Ash Tewari’s 10-Year Voyage at the Department of Urology.”

Participants included 90 of the world’s most renowned experts from more than 20 countries.

Three Mount Sinai leaders opened the symposium: Dr. Tewari, Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai, and David Reich, MD, President,The Mount Sinai Hospital and Mount Sinai Queens. Their insightful opening remarks set the tone for what was to be an intensive three-day exploration of the latest advancements and challenges in urologic cancer care.

One of the symposium’s highlights was an engaging presentation by best-selling author Deepak Chopra, MD, a pioneer in integrative medicine and a prolific writer titled “Major Breakthroughs in the Science of Healing.” Dr. Chopra’s talk focused on integrating AI with the holistic interplay of mind, body, and spirit in medical science.

The event also highlighted technological innovation in medical communication and education, featuring state-of-the-art holographic presentations by Declan Murphy, MB, BCh, BaO, Consultant Urologist, Peter MacCallum Cancer Centre, Melbourne, Australia, and Alberto Breda, MD, PHD, Chief, Uro-Oncology Unit and Kidney Transplant Surgical Program at Fundació Puigvert in Barcelona.

Additionally, a stimulating debate between Mount Sinai radiation oncologist Richard Stock, MD, and robotic surgery pioneer Mani Menon, MD, Professor and Chief of Strategy and Innovation at the Department of Urology, offered contrasting perspectives on treating intermediate-risk prostate cancer.

Ketan Badani, MD, the Department’s Vice Chair and Director of Robotic Operations, and other renowned speakers enriched the symposium with their expertise on modern surgical techniques in kidney cancer, fostering a collaborative learning culture.

The symposium’s final day, led by Peter Wiklund, MD, PhD, Professor and Director of the Bladder Cancer Program, showcased advanced surgical procedures and a panel discussion with Reza Mehrazin, MD, Associate Professor, and John Sfakianos, MD, Assistant Professor, providing deeper insights into bladder cancer management.

Interactive sessions, including live surgical demonstrations, 3D video presentations, and hands-on experiences in simulation laboratories, underscored the event’s commitment to innovative and experiential learning.

Reflecting on the symposium’s impact, Dr. Tewari noted, “This gathering served as a dynamic platform for exploring the various facets of urology and robotic surgery. The exchange of ideas and insights among our peers underscores our collective capacity to shape the future of urologic oncology significantly.”

 

Watch a slideshow of photos from the event:

Institute for Health Equity Research Holds Inaugural Symposium to Exchange Ideas and Propel Research

Carol Horowitz, MD, MPH, left, and Lynne D. Richardson, MD, directors of the Institute for Health Equity Research, at its inaugural symposium.

As part of its mission to elevate the science of heath equity, the Institute for Health Equity Research (IHER) held its inaugural symposium, one of the first major milestones in a new partnership between IHER and Royalty Pharma, established in 2022, to build an infrastructure to exchange ideas and propel research collaboration.

“We founded IHER to elevate the science of health equity to the same level as other important areas of science that are studied here at the Icahn School of Medicine at Mount Sinai. We are very pleased to partner with Royalty Pharma as we engage other leaders in the field to bring this conversation to the forefront,” says IHER Co-Director Lynne D. Richardson, MD, Professor of Emergency Medicine, and Population Health Science and Policy, Icahn Mount Sinai.

“We designed the symposium to explore two main areas of priority: collecting strong data to transform clinical care and building partnerships for cross-sector engagement,” says IHER Director Carol Horowitz, MD, MPH, Professor, Population Health Science and Policy, and Medicine, and Dean for Gender Equity in Science and Medicine.

The symposium, titled “From Inquiry to Action,” was held Friday, December 1, at Icahn Mount Sinai. The Institute was founded in 2020.

“To help us craft solutions that will really make a difference, we need community-based organizations to help us understand the lived experiences within the community,” says Dr. Horowitz. “We can’t come into a community without understanding the social determinants of health at a local level: Do members of the community have access to nutritious food, do they live in safe housing, how clean is the air?  Our institute is looking at all these different influences and working hand-in-hand with people from local communities to develop programs that tangibly improve their health.”

Dr. Horowitz moderated a panel of experts from community-based organizations, academia, and the public sector. The panelists described the challenges and possibilities of community-engaged equity initiatives.

“The use of data, both from health care organizations and from other sectors, is key to addressing structural inequities and achieving health equity,” says Dr. Richardson.

Dr. Richardson moderated a diverse panel that included leaders from health care, payors, and industry who described how cross sector data on health status and health care utilization can be linked to individual data on social risks and needs and to neighborhood data on physical and social exposures that threaten health. The panelists presented examples of how data can be harnessed to inform organizational strategies to promote equity and discussed the considerable challenges of using data in ethical and unbiased ways that do not adversely impact minoritized populations.

Through many voices and viewpoints, a familiar pattern emerged: a sobering story of a broken system that continues to fail its most vulnerable patients.

The keynote speaker, former New York State Health Commissioner, Mary T. Bassett, MD, MPH, FXB Professor of the Practice of Health and Human Rights, Harvard T. H. Chan School of Public Health, described the unequal landscape of medicine over time and across the country.  At one point, she reminded the audience that it was only 15 years ago that the American Medical Association, the voice of organized medicine in the United States, acknowledged that it had wrongly allowed, even endorsed, policies that prohibited Black physicians from practicing in hospitals.

“That Black individuals disproportionately suffer from kidney failure is one of many manifestations of unequal care that has its seed in a very long list of inequities,” says Dinushika Mohottige, MD, MPH.

Two members of the IHER faculty presented their research, beginning with Dinushika Mohottige, MD, MPH, Assistant Professor, Population Science and Policy, and Medicine (Nephrology). Dr. Mohottige, who specializes in kidney health equity, led her presentation with a startling statistic: While 13 percent of the U.S. population is Black, Black Americans make up 35 percent of individuals receiving dialysis care.

“That Black individuals disproportionately suffer from kidney failure is one of many manifestations of unequal care that has its seed in a very long list of inequities from underinsurance, limited access to doctors, and a wide spectrum of unequal social determinants working against them. Kidney patients, specifically, also experience the lingering challenges resulting from a race-based algorithm that has been phased out but which previously limited the possibilities for transplantation for Black patients,” says Dr. Mohottige.

Dr. Mohottige has found partners to leverage equity data to reform transplant roadblocks. To address the eGFR algorithm, a race-based correction that had the effect of overestimating a Black patient’s kidney function, she has worked with colleagues to help implement restorative policies to require unbiased, race neutral estimates of kidney health that began in January 2023.

She discussed cascading barriers to transplantation that begin with challenges to transplant referral and evaluation.

“These challenges can include trauma, discrimination, financial or employment instability, mental health or substance abuse, underinsurance, food insecurity or transportation barriers. If you are an individual with any of these challenges, imagine how hard it is to take even the simplest of steps in this long journey,” says Dr. Mohottige. “A fundamental part of change is simply making sure providers know that any of these obstacles can be an impediment, and we know from the data that clinicians are not always aware of these roadblocks.  To address this, we are working with multiple partners to build training programs to fill some of the education gaps among providers who treat these vulnerable populations.”

“Faith-based organizations are a natural place to integrate mental health supports,” says Sidney Hankerson, MD, MBA.

Sidney Hankerson, MD, MBA, Associate Professor, Population Health Science Policy, and Psychiatry, and a Mount Sinai Biomedical Laureate, described several initiatives designed to address mental health inequities in New York City. African Americans and Mexican Americans, he told his listeners, have the lowest rates of depression treatment in the United States. Dr. Hankerson is working to address this problem through partnerships he has developed with faith-based organizations throughout the NYC area and Westchester County.

Through the First Corinthians Baptist Church in Central Harlem, he has collaborated with church leadership to develop free mental health care embedded in their HOPE (Healing on Purpose and Evolving) Center. With a new grant from the Mother Cabrini Health Foundation, he is expanding the program by training psychiatry residents at Mount Sinai in the principles of community engagement and supervising residents who provide direct clinical services at the HOPE Center.

Through the TRIUMPH (TRansformIng yoUr Mental health through Prayer and Healing (Triumph Together), he has developed an eight- week training program to teach motivational interviewing in churches in the five boroughs and Westchester. TRIUMPH aims to address racial and gender disparities that affect Blacks and other communities of color by promoting mental health equity, increasing mental health literacy, reducing stigma, and improving access to care for depression, anxiety, prolonged grief, and drug use.

“More people initially seek help for depression from clergy than from psychiatrists.  So, faith-based organizations are a natural place to integrate mental health supports,” says Dr. Hankerson.

Through grant funding from the Scarlett Feather Foundation, Dr. Hankerson is now launching “Brothers Connect,” a suicide prevention program aimed at black youth ages 13-19. The program will roll out in YMCA’s across the city to reach boys participating in basketball leagues.

“All of these programs have one thing in common: They are all created as community-based networks of care to reach vulnerable populations where they are,” says Dr. Hankerson. “Our churches and local Y’s are safe havens where we can have the greatest impact. These programs underline how important it is for an institution like Mount Sinai to find partners in the community to reach patients who aren’t likely to walk through our doors and ask for help.”

Annual Gala Benefits the Louis Armstrong Center for Music and Medicine

Samara Joy, multi-Grammy Award-winning vocalist, singing “What a Wonderful World” at the annual “Wonderful World” gala benefiting the Louis Armstrong Center for Music and Medicine.

The 18th annual “Wonderful World” gala benefiting the Louis Armstrong Center for Music and Medicine, was a festive evening of jazz and expressions of gratitude to three honorees for making the world more wonderful through their contributions to music and music therapy.

The event, held Monday, October 23 at the Angel Orensanz Foundation and hosted by the Wonderful World Friends of Music Therapy Inc., honors the legacy of the Louis Armstrong Department of Music Therapy and the Department’s commitment to music therapy at Mount Sinai hospitals.

The evening recognizes a dynamic group of individuals chosen from a variety of fields including music and medicine, in addition to patients who have benefitted from receiving music therapy at Mount Sinai hospitals.

From left: Honorees Zoë Brecher, Manjeet Chadha MD, and Samara Joy.

This year’s honorees were Manjeet Chadha, MD, Director, Department of Radiation Oncology, Mount Sinai Downtown; Samara Joy, the multi-Grammy Award-winning vocalist, who was presented the Phoebe Jacobs Award by renowned jazz trumpeter Jon Faddis; and patient Zoë Brecher, a patient of the Louis Armstrong Center who is the drummer of Bruce Springsteen’s ‘Nightshift’ band.

The gala was hosted by Mercedes Ellington, dancer, choreographer, and granddaughter of Duke Ellington, and Bill Daughtry, the retired radio and TV host. The co-chairs were Robert Lande, President and Director at FXCM and Chief Financial Officer of Forex Capital Markets, and Kim Polson, from the Louis Armstrong Center for Music and Medicine’s Steering Committee.

The event featured an opening performance by Aneesa Folds from the Broadway production of Freestyle Love Supreme, with Dizzy Senze, Anabelle Luke, and David Bradshaw. Jazz ensued throughout the evening with saxophonist Erik Lawrence, Matthew Munisteri, jazz guitarist, and bass player Russell Hall who accompanied Samara Joy. Her voice, recalling the memory of Ella Fitzgerald, enraptured the more than 200 attendees with her rendition of Louis Armstrong’s “What a Wonderful World.”

Joanne V. Loewy, left, and Samara Joy.

Ricky Riccardi, archivist from the Louis Armstrong House Museum in Queens, shared Louis Armstrong  memorabilia. There was also Pop’s Food Court and a silent auction.

“This event highlights our commitment to music therapy, as the doctors, musicians, and patients who attend enjoy hearing about Louis’ love of music and people from all walks of life. This gala supports our care of patients and research—from neonatal care to oncology, Alzheimer’s disease, and psychiatry,” said Joanne V. Loewy, DA, LCAT, MT-BC, Founder and Director of the Louis Armstrong Center for Music and Medicine, which offers music therapy services throughout the Mount Sinai Health System.

This year Dr. Loewy and the Loewy Lab received funding from the National Institute of Health for her study of how music therapy addresses chronic stress in Black pregnant women through metabolomic pathways, and she received additional funding from the National Endowment for the Arts to study how music influences depression across several disease cohorts.

The Department of Music Therapy, with support from the Louis Armstrong Educational Foundation and other grants, provides a range of clinical services for infants, children, and adults, and day treatment at the Mount Sinai-Union Square clinic and within the community. Its music therapists are licensed and board certified to provide care that complements medical treatment, assisting with sedation, pain management, and neurologic and respiratory function.

Second Book Celebrates Cancer Patients’ Prose During Pandemic

Alison Snow, PhD, LCSW-R (left), Emily Rubin, and Manjeet Chadha, MD

Cancer patients had much to express during the COVID-19 pandemic, and their heartfelt stories can now be read in a new book, The Write Treatment Anthology Volume 2: The Pandemic Years (Write Treatment Anthology Series). The book includes essays, short stories, and poems from 15 cancer patients, survivors, and caregivers—all members of the Write Treatment Workshops for Mount Sinai Hospitals.

“During the pandemic, in the spring of 2021, I found this loving and supportive group while they met on Zoom,” writes workshop member Liz York in an excerpt from the anthology. “It was difficult to meet people who understood the emotional challenges of cancer, so the group immediately became important to me.”

The sentiment is shared by novelist Emily Rubin, workshop founder and cancer survivor who spoke to a large audience of fellow patients, their families, and caregivers at a recent book launch for the anthology on Wednesday, November 15, held at Mount Sinai-Union Square. She was introduced by Manjeet Chadha, MD, Director, Department of Radiation Oncology, Mount Sinai Downtown, and Professor, Radiation Oncology, Icahn School of Medicine at Mount Sinai, who described her as a “guiding light and a huge resource in helping many of our patients find an outlet through their writing.”

As Ms. Rubin took the microphone, she told the packed auditorium that running the workshops has helped her to “connect through the creative act of writing with so many who, like me, have been participants in these workshops, come and stay with a yearning to tell stories and hear those of others. Together we have built a supportive, creative community of writers.”

The Write Treatment Workshops: Evolution and Founding

Emily Rubin, novelist and workshop co-founder

Emily Rubin, novelist and workshop co-founder

A co-editor of the anthology, Ms. Rubin founded one of the workshops in 2011 after she completed breast cancer treatment at Mount Sinai Beth Israel. The other workshop was started by Susan Ribner, an author who was treated for ovarian cancer at Mount Sinai West. While the two coincidentally formed the workshops around the same time, they had met years before at an Aikido dojo, a type of martial arts gym, in Chelsea. They collaborated on workshops and book readings, and after Ms. Ribner went into hospice care, Ms. Rubin took over both groups. Ms. Ribner died in 2014.

Before the pandemic, the workshops were held in-person at the Blavatnik Family Chelsea Medical Center and at Mount Sinai West but moved to Zoom during the pandemic. While the workshops continue to be held virtually, they stick to the same routine they have always followed since their origins: Ms. Rubin emails prompts, such as quotes, cards, or photographs, to participants to spur their imaginations. Each participant then writes for about a half-hour, aiming to create a short, finished product. About 600 people now take part in the workshops regularly—a number that has doubled since the workshops began.

The book, published on Amazon.com through grants and crowdfunding, includes an in-memoriam section with writings from those who have died. In one excerpt, Susan Masaad, MD (1938-2021), writes of a virtual visit with her gastrointestinal oncologist of whom she was very fond: “I have come to appreciate his wonkiness, encyclopedic knowledge of all the ways we can slash and burn the cancer, as well as his absolutely exquisite taste in clothing…”

In another excerpt, patient Norman Ford (1935-2021) offers words of encouragement: “To you my cancer-laden brothers and sisters I have a message. This is not a chore. In the thoughts and feelings on display you expressed courage, anger, uncertainty, and more…”

Copies of the The Write Treatment Anthology Volume 2: The Pandemic Years (Write Treatment Anthology Series)

The Write Treatment Anthology Volume 2: The Pandemic Years (Write Treatment Anthology Series) follows Volume 1, published in 2022, which includes essays, short stories, and poems from 23 workshop participants. During the recent book launch, Alison Snow, PhD, LCSW-R, Director, Cancer Center Supportive Services at Mount Sinai Downtown Cancer Centers, called the second anthology’s publication “an extraordinary accomplishment” for the hundreds of Mount Sinai patients who continue to live—and write—with cancer.

A “Profound Honor”: Mount Sinai Partnership Expands Health Care to Thousands in Guyana

Rachel Vreeman, MD, MS, speaks with Frank Anthony, MD, MPH, Minister of Health, Guyana (right)

The Icahn School of Medicine at Mount Sinai is seizing “an amazing opportunity” in global public health in a three-year initiative that is expanding health care to Guyana’s more than 800,000 citizens. Launched in 2022, the initiative is a partnership among Mount Sinai, the Hess Corporation, and the government of Guyana, and it is already bringing crucial health screenings to roughly half the nation’s eligible children.

“It is a profound honor to serve the people of Guyana in this mission to give everyone the best opportunity for a healthy and long life,” says Jeremy Boal, MD, Chief Clinical Officer of the Mount Sinai Health System, who is overseeing Mount Sinai’s efforts under the initiative.

Guyana is a racially and ethnically diverse nation at the northern edge of South America, with strong historic and cultural ties with nearby Caribbean nations. The nation entered a transformative era in 2015, when nearly 11 billion barrels of crude oil reserves were discovered offshore and its government began making plans to invest in much-needed infrastructure in many areas, including health care. Guyana’s National Healthcare Initiative was launched after John Hess, Chief Executive Officer of Hess and a member of Mount Sinai’s Boards of Trustees, approached Mount Sinai about partnering with Guyana’s government and Hess to expand health care in the country. The collaboration will make health care more accessible even to its most vulnerable citizens, including pregnant people and adults living with diabetes or cancer.

Working closely with Guyana’s government, a 40-member project team of experts from the Mount Sinai Health System are providing thought partnership to the country’s leadership to implement a range of improvements to the national health infrastructure of Guyana. These teams are led by the Mount Sinai’s Arnhold Institute of Global Health and Mount Sinai International, organizations dedicated to advancing Mount Sinai’s mission of delivering innovative, high-quality health care around the globe.

Initial steps: Increasing access to children’s health care, primary care for diabetics, and a “world class” pathology lab

Already underway is a national child and youth health initiative, the first primary care program for children in Guyana. Launched in August 2023, the program provides comprehensive health exams for all nursery school students in Guyana, children aged three to five years old. Within its first month the program conducted health screenings—including vision, hearing, and dental evaluation—on 50 percent of the eligible children in Guyana, and the program is now reaching every region of the country, including remote regions accessible only by boat or plane.

“We’re really proud to move this bold children’s health initiative forward with the Guyana Ministry of Health and Ministry of Education,” says Rachel Vreeman, MD, MS, Director of the Arnhold Institute for Global Health, which is guiding the program. “It provides the critical steps toward implementing a primary care system and more universal health coverage. We’re providing screenings that let us identify children’s health issues early and connect families and communities and schools with the health centers in a new way.”

Comprehensive school health screening in the indigenous community of Karasabai in Region 9, Guyana

The next step is to enhance the national primary care program for adults, which will initially focus on diabetes screenings. After developing new national guidelines on diabetes in partnership with Guyana’s Ministry of Health, Mount Sinai experts trained Guyanese health professionals to implement high quality screening and care for diabetes at every level of the health system. Under the program, which also supplies medication and equipment, the Guyanese providers will, in turn, travel across the country to train health professionals in their local communities.

“The diabetes care platform is a model for other ‘train the trainer’ programs and primary care efforts, which will expand to provide screening and care for health challenges across Guyana, including high blood pressure, cancer screening, mental health screening, and other chronic diseases,” Dr. Vreeman says. The diabetes training is accompanied by efforts to build an infrastructure of expertise, supplies, and referral pathways, explains Dr. Vreeman, noting that expanding primary care services throughout the country will prevent patients from having to travel long distances for care. The Arnhold Institute is also guiding the country in building a more robust health care workforce, as well as the eventual rollout of a national electronic health records system and national health information system strategy.

The health care initiative will also expand specialty and tertiary health care at both public and private health care facilities throughout the country, particularly in cancer and cardiovascular care. Under the partnership, Mount Sinai International is working with Guyana’s government to develop a strategic plan that will determine how and where these services will be implemented, and how they will be funded and staffed. While most of these services are still in the planning stages, a telepathology lab is expected to be in operation by January 2024. Using advanced remote technology, the lab will allow doctors in Georgetown, the nation’s capital, to work with Mount Sinai pathologists in New York to diagnose patients in Guyana.

“The technology will decrease the wait time in Guyana for high-quality pathology readings from two to three months to few days,” says Szabi Dorotovics, MD, MBA, President, Mount Sinai International, who is overseeing these efforts. “I don’t think I have to tell you how much of a difference that can make, especially in cancer care. The quality of the readings will be world class.”

Guiding quality improvements at Guyana’s largest hospital

Under the initiative, Mount Sinai is also consulting on quality and operational improvements with leaders from Georgetown Public Hospital Corporation in Georgetown, Guyana’s largest hospital, where roughly half of patients are women seeking maternity care. These include enhancements to its neonatal intensive care unit; accident and emergency services; fire and life safety procedures; information technology; pharmacy services; supplies, equipment, and technology; minor renovations to the hospital campus, and more. A major challenge faced by hospital leaders in rolling out these improvements is a lack of resources, including a shortage of nurses and equipment.

“What we have to do is work with them, given the constraints, and figure out what can we do,” says Art Gianelli, MBA, MPH, FACHE, Chief Transformation Officer for the Mount Sinai Health System, who is leading these efforts with the Mount Sinai International Group. “Maybe we can’t do what is ideal, but we can take practical steps to improve all of the areas.”

Most of these improvements involve process changes that make up the foundation of good care, explains Mr. Gianelli, some of which are already underway. “The next step is to build on this foundational work and start to drive changes in outcomes, but you have to start at the beginning.”

Hospital leaders have already made a number of quality improvements, such as installing soap dispensers throughout the building to help reduce the spread of hospital-acquired infections, and deploying hospital administrator “safety huddles” to improve awareness of potential safety issues. For Guyana’s largest and busiest hospital, where many patients travel long distances to obtain care, these changes are sure to have a positive “ripple effect” across the country, Mr. Gianelli says.

While Guyana’s health care initiative is still in its early phases, it is providing valuable insight into how to target, at a national level, social determinants of disease. This will allow the country to address problems early and provide community-based prevention strategies, according to Dr. Vreeman.

“Our teams feel really privileged to be serving as this partner for Guyana’s Ministry of Health,” says Dr. Vreeman, Chair of Global Health and Health System Design at the Icahn School of Medicine at Mount Sinai. “It’s an amazing opportunity to be able to bring up to scale some of the most evidence-based practices for what works in global settings. Through this initiative, Guyana is improving access to care, especially for marginalized and vulnerable children, and for people living in remote communities who have often experienced systemic inequities.”

Pin It on Pinterest